These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
400 related items for PubMed ID: 6348093
21. Synthesis of complement components C5, C6, C7, C8 and C9 in vitro by human monocytes and assembly of the terminal complement complex. Hetland G, Johnson E, Falk RJ, Eskeland T. Scand J Immunol; 1986 Oct; 24(4):421-8. PubMed ID: 3764345 [Abstract] [Full Text] [Related]
22. The attack phase of human complement: differentiation between membrane binding and complex formation by the detection of neoantigen expression in situ. A morphometric immunoferritin study. Balkarowa-Ständer J, Rother U, Rauterberg EW. J Immunol; 1981 Sep; 127(3):1089-93. PubMed ID: 7264298 [Abstract] [Full Text] [Related]
23. Assembly of the functional membrane attack complex of human complement: formation of disulfide-linked C9 dimers. Ware CF, Kolb WP. Proc Natl Acad Sci U S A; 1981 Oct; 78(10):6426-30. PubMed ID: 6796960 [Abstract] [Full Text] [Related]
24. Complement resistance in Borrelia burgdorferi strain 297: outer membrane proteins prevent MAC formation at lysis susceptible sites. Patarakul K, Cole MF, Hughes CA. Microb Pathog; 1999 Jul; 27(1):25-41. PubMed ID: 10371707 [Abstract] [Full Text] [Related]
25. Enhanced reactive lysis of paroxysmal nocturnal hemoglobinuria erythrocytes by C5b-9 does not involve increased C7 binding or cell-bound C3b. Rosenfeld SI, Jenkins DE, Leddy JP. J Immunol; 1985 Jan; 134(1):506-11. PubMed ID: 3964820 [Abstract] [Full Text] [Related]
26. Cell populations and membrane attack complex in glomeruli of patients with post-streptococcal glomerulonephritis: identification using monoclonal antibodies by indirect immunofluorescence. Parra G, Platt JL, Falk RJ, Rodriguez-Iturbe B, Michael AF. Clin Immunol Immunopathol; 1984 Dec; 33(3):324-32. PubMed ID: 6388925 [Abstract] [Full Text] [Related]
27. Human alveolar macrophages synthesize active complement components C6, C7, and C8 in vitro. Pettersen HB, Johnson E, Hetland G. Scand J Immunol; 1987 Jun; 25(6):567-70. PubMed ID: 3602933 [Abstract] [Full Text] [Related]
28. Protection of gingival epithelium against complement-mediated damage by strong expression of the membrane attack complex inhibitor protectin (CD59). Rautemaa R, Meri S. J Dent Res; 1996 Jan; 75(1):568-74. PubMed ID: 8655761 [Abstract] [Full Text] [Related]
29. Several epitopes on native human complement C9 are involved in interaction with the C5b-8 complex and other C9 molecules. Kontermann R, Deppisch R, Rauterberg EW. Eur J Immunol; 1990 Mar; 20(3):623-8. PubMed ID: 1690659 [Abstract] [Full Text] [Related]
30. Complement fixation by pemphigus antibody. V. Assembly of the membrane attack complex on cultured human keratinocytes. Xia P, Jordon RE, Geoghegan WD. J Clin Invest; 1988 Dec; 82(6):1939-47. PubMed ID: 2461964 [Abstract] [Full Text] [Related]
31. Interactions of soluble CD59 with the terminal complement complexes. CD59 and C9 compete for a nascent epitope on C8. Lehto T, Meri S. J Immunol; 1993 Nov 01; 151(9):4941-9. PubMed ID: 7691959 [Abstract] [Full Text] [Related]
32. The complement-inhibitory activity of CD59 resides in its capacity to block incorporation of C9 into membrane C5b-9. Rollins SA, Sims PJ. J Immunol; 1990 May 01; 144(9):3478-83. PubMed ID: 1691760 [Abstract] [Full Text] [Related]
33. Monoclonal antibodies directed against gonococcal protein I vary in bactericidal activity. Joiner KA, Warren KA, Tam M, Frank MM. J Immunol; 1985 May 01; 134(5):3411-9. PubMed ID: 3920319 [Abstract] [Full Text] [Related]
34. The terminal complement complex in sera deficient in the eighth component of complement (C8). Mollnes TE, Lea T, Rogde S, Tedesco F. Scand J Immunol; 1986 Sep 01; 24(3):307-12. PubMed ID: 3749815 [Abstract] [Full Text] [Related]
35. Human peritoneal macrophages. Production in vitro of the active terminal complement components C5 to C9 and a functional alternative pathway of complement. Brief report. Hetland G, Bungum L. APMIS; 1988 Jan 01; 96(1):89-92. PubMed ID: 3345254 [Abstract] [Full Text] [Related]
36. Inhibition of C9 polymerization within the SC5b-9 complex of complement by S-protein. Podack ER, Preissner KT, Müller-Eberhard HJ. Acta Pathol Microbiol Immunol Scand Suppl; 1984 Jan 01; 284():89-96. PubMed ID: 6587746 [Abstract] [Full Text] [Related]
37. Antibodies That Efficiently Form Hexamers upon Antigen Binding Can Induce Complement-Dependent Cytotoxicity under Complement-Limiting Conditions. Cook EM, Lindorfer MA, van der Horst H, Oostindie S, Beurskens FJ, Schuurman J, Zent CS, Burack R, Parren PW, Taylor RP. J Immunol; 2016 Sep 01; 197(5):1762-75. PubMed ID: 27474078 [Abstract] [Full Text] [Related]
38. Ultrastructure of the membrane attack complex of complement: detection of the tetramolecular C9-polymerizing complex C5b-8. Tschopp J, Podack ER, Müller-Eberhard HJ. Proc Natl Acad Sci U S A; 1982 Dec 01; 79(23):7474-8. PubMed ID: 6961424 [Abstract] [Full Text] [Related]
39. Studies of the mechanism of bacterial resistance to complement-mediated killing. V. IgG and F(ab')2 mediate killing of E. coli 0111B4 by the alternative complement pathway without increasing C5b-9 deposition. Joiner KA, Goldman RC, Hammer CH, Leive L, Frank MM. J Immunol; 1983 Nov 01; 131(5):2563-9. PubMed ID: 6355296 [Abstract] [Full Text] [Related]
40. A unique epitope exposed in native complement component C9 and hidden in the terminal SC5b-9 complex enables selective detection and quantification of non-activated C9. Mollnes TE, Tschopp J. J Immunol Methods; 1987 Jun 26; 100(1-2):215-21. PubMed ID: 2439601 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]